The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Smoothened Variants Explain the Majority of Drug Resistance in Basal Cell Carcinoma
Open accessAbstract
Advanced basal cell carcinomas (BCCs) frequently acquire resistance to Smoothened (SMO) inhibitors through unknown mechanisms. Here we identify SMO mutations in 50% (22 of 44) of resistant BCCs and show that these mutations maintain Hedgehog signaling in the presence of SMO inhibitors. Alterations include four ligand binding pocket mutations defining sites of inhibitor binding and four variants conferring constitutive activity and inhibitor resistance, illuminating pivotal residues that ensure receptor autoinhibition. In the presence of a SMO inhibitor, tumor cells containing either class of SMO mutants effectively outcompete cells containing the wild-type SMO. Finally, we show that both classes of SMO variants respond to aPKC-ι/λ or GLI2 inhibitors that operate downstream of SMO, setting the stage for the clinical use of GLI antagonists.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mapping and quantifying mammalian transcriptomes by RNA-Seq
Mortazavi, A., Williams, B. A., McCue, K., Schaeffer, L., & Wold, B. (2008) · Nature Methods · doi:10.1038/nmeth.1226 · Cited by 13,696
COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer
Forbes, S. A., Bindal, N., Bamford, S., Cole, C., Kok, C. Y., Beare, D., Jia, M., Shepherd, R., Leung, K., Menzies, A., et al. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkq929 · Cited by 2,278
Efficacy and Safety of Vismodegib in Advanced Basal-Cell Carcinoma
Sekulic, A., Migden, M. R., Oro, A. E., Dirix, L., Lewis, K. D., Hainsworth, J. D., Solomon, J. A., Yoo, S., Arron, S. T., Friedlander, P. A., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1113713 · Cited by 1,464
Self-citationActivating Smoothened mutations in sporadic basal-cell carcinoma
Xie, J., Murone, M., Luoh, S.-M., Ryan, A., Gu, Q., Zhang, C., Bonifas, J. M., Lam, C.-W., Hynes, M., Goddard, A., et al. (1998) · Nature · doi:10.1038/34201 · Cited by 1,334
Incidence Estimate of Nonmelanoma Skin Cancer in the United States, 2006
Rogers, H. W., Weinstock, M. A., Harris, A. R., Hinckley, M. R., Feldman, S. R., Fleischer, A. B., & Coldiron, B. M. (2010) · Archives of Dermatology · doi:10.1001/archdermatol.2010.19 · Cited by 1,185
Structure-Function of the G Protein–Coupled Receptor Superfamily
Katritch, V., Cherezov, V., & Stevens, R. C. (2013) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-032112-135923 · Cited by 1,054
Smoothened Mutation Confers Resistance to a Hedgehog Pathway Inhibitor in Medulloblastoma
Yauch, R. L., Dijkgraaf, G. J. P., Alicke, B., Januario, T., Ahn, C. P., Holcomb, T., Pujara, K., Stinson, J., Callahan, C. A., Tang, T., et al. (2009) · Science · doi:10.1126/science.1179386 · Cited by 839
Genome Sequencing of SHH Medulloblastoma Predicts Genotype-Related Response to Smoothened Inhibition
Kool, M., Jones, D. T. W., Jäger, N., Northcott, P. A., Pugh, T. J., Hovestadt, V., Piro, R. M., Esparza, L. A., Markant, S. L., Remke, M., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.02.004 · Cited by 762
Buonamici, S., Williams, J., Morrissey, M., Wang, A., Guo, R., Vattay, A., Hsiao, K., Yuan, J., Green, J., Ospina, B., et al. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3001599 · Cited by 562
Unraveling the therapeutic potential of the Hedgehog pathway in cancer
Amakye, D., Jagani, Z., & Dorsch, M. (2013) · Nature Medicine · doi:10.1038/nm.3389 · Cited by 547
Inhibiting the Hedgehog Pathway in Patients with the Basal-Cell Nevus Syndrome
Tang, J. Y., Mackay-Wiggan, J. M., Aszterbaum, M., Yauch, R. L., Lindgren, J., Chang, K., Coppola, C., Chanana, A. M., Marji, J., Bickers, D. R., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1113538 · Cited by 547
Self-citationStructure of the human smoothened receptor bound to an antitumour agent
Wang, C., Wu, H., Katritch, V., Han, G. W., Huang, X.-P., Liu, W., Siu, F. Y., Roth, B. L., Cherezov, V., & Stevens, R. C. (2013) · Nature · doi:10.1038/nature12167 · Cited by 464
Extracting Biological Meaning from Large Gene Lists with DAVID
Huang, D. W., Sherman, B. T., Zheng, X., Yang, J., Imamichi, T., Stephens, R., & Lempicki, R. A. (2009) · Current Protocols in Bioinformatics · doi:10.1002/0471250953.bi1311s27 · Cited by 456
Somatic mutations in the PTCH,SMOH,SUFUH and TP53 genes in sporadic basal cell carcinomas
Reifenberger, J., Wolter, M., Knobbe, C. B., Köhler, B., Schönicke, A., Scharwächter, C., Kumar, K., Blaschke, B., Ruzicka, T., & Reifenberger, G. (2005) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2005.06353.x · Cited by 399
Dijkgraaf, G. J. P., Alicke, B., Weinmann, L., Januario, T., West, K., Modrusan, Z., Burdick, D., Goldsmith, R., Robarge, K., Sutherlin, D., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-2876 · Cited by 363
The Crosstalk of mTOR/S6K1 and Hedgehog Pathways
Wang, Y., Ding, Q., Yen, C.-J., Xia, W., Izzo, J. G., Lang, J.-Y., Li, C.-W., Hsu, J. L., Miller, S. A., Wang, X., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2011.12.028 · Cited by 346
Kim, J., Aftab, B. T., Tang, J. Y., Kim, D., Lee, A. H., Rezaee, M., Kim, J., Chen, B., King, E. M., Borodovsky, A., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2012.11.017 · Cited by 346
Self-citationEpigenetic targeting of Hedgehog pathway transcriptional output through BET bromodomain inhibition
Tang, Y., Gholamin, S., Schubert, S., Willardson, M. I., Lee, A., Bandopadhayay, P., Bergthold, G., Masoud, S., Nguyen, B., Vue, N., et al. (2014) · Nature Medicine · doi:10.1038/nm.3613 · Cited by 314
Self-citationActivation of heterotrimeric G proteins by Smoothened
Riobo, N. A., Saucy, B., DiLizio, C., & Manning, D. R. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0600880103 · Cited by 244
GLI activation by atypical protein kinase C ι/λ regulates the growth of basal cell carcinomas
Atwood, S. X., Li, M., Lee, A., Tang, J. Y., & Oro, A. E. (2013) · Nature · doi:10.1038/nature11889 · Cited by 237
Self-citationMutational Landscape of Basal Cell Carcinomas by Whole-Exome Sequencing
Jayaraman, S. S., Rayhan, D. J., Hazany, S., & Kolodney, M. S. (2014) · Journal of Investigative Dermatology · doi:10.1038/jid.2013.276 · Cited by 221
Gajjar, A., Stewart, C. F., Ellison, D. W., Kaste, S., Kun, L. E., Packer, R. J., Goldman, S., Chintagumpala, M., Wallace, D., Takebe, N., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-1425 · Cited by 211
Axelson, M., Liu, K., Jiang, X., He, K., Wang, J., Zhao, H., Kufrin, D., Palmby, T., Dong, Z., Russell, A. M., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-1956 · Cited by 185
Initial Assessment of Tumor Regrowth After Vismodegib in Advanced Basal Cell Carcinoma
Chang, A. L. S., & Oro, A. E. (2012) · Archives of Dermatology · doi:10.1001/archdermatol.2012.2354 · Cited by 176
Self-citationEvaluating Smoothened as a G-protein-coupled receptor for Hedgehog signalling
Ayers, K. L., & Thérond, P. P. (2010) · Trends in Cell Biology · doi:10.1016/j.tcb.2010.02.002 · Cited by 130
Hedgehog pathway inhibition and the race against tumor evolution
Atwood, S. X., Chang, A. L. S., & Oro, A. E. (2012) · The Journal of Cell Biology · doi:10.1083/jcb.201207140 · Cited by 118
Self-citationPTEN Loss Mitigates the Response of Medulloblastoma to Hedgehog Pathway Inhibition
Metcalfe, C., Alicke, B., Crow, A., Lamoureux, M., Dijkgraaf, G. J. P., Peale, F. V., Jr., Gould, S. E., & de Sauvage, F. J. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-1222 · Cited by 65
Dey, J., Ditzler, S. H., Knoblaugh, S. E., Hatton, B. A., Schelter, J. M., Cleary, M. A., Mecham, B., Rorke-Adams, L. B., & Olson, J. M. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.00862-12 · Cited by 47
Cited by
Clonal replacement of tumor-specific T cells following PD-1 blockade
Yost, K. E., Satpathy, A. T., Wells, D. K., Qi, Y., Wang, C., Kageyama, R., McNamara, K. L., Granja, J. M., Sarin, K. Y., Brown, R. A., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0522-3 · Cited by 1,534
Self-citationThe great escape: tumour cell plasticity in resistance to targeted therapy
Boumahdi, S., & de Sauvage, F. J. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0044-1 · Cited by 761
Clara, J. A., Monge, C., Yang, Y., & Takebe, N. (2020) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-019-0293-2 · Cited by 752
Peris, K., Fargnoli, M. C., Garbe, C., Kaufmann, R., Bastholt, L., Seguin, N. B., Bataille, V., Marmol, V. D., Dummer, R., Harwood, C. A., et al. (2019) · European Journal of Cancer · doi:10.1016/j.ejca.2019.06.003 · Cited by 599
Cameron, M. C., Lee, E., Hibler, B. P., Barker, C. A., Mori, S., Cordova, M., Nehal, K. S., & Rossi, A. M. (2019) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2018.03.060 · Cited by 525
Metadata
- Authors
- Atwood, S. X., Sarin, K. Y., Whitson, R. J., Li, J. R., Kim, G., Rezaee, M., Ally, M. S., Kim, J., Yao, C., Chang, A. L. S., Oro, A. E., & Tang, J. Y.
- Venue
- Cancer Cell
- Publisher
- Elsevier BV
- Published
- 2015-03
- Volume
- 27
- Issue
- 3
- Pages
- 342-353
- ISSN
- 1535-6108 (ISSN-L)
- OpenAlex
- W2108444995
- Cited by
- 404
- References
- 28
- FWCI
- 18.01
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.